Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Anorexia Nervosa with Significantly Low Body Weight
Interventions
DRUG

Mirtazapine

Patients will be prescribed a dosage of 15 mg per day. Dose will not be escalated.

DRUG

Olanzapine

the participant will be prescribed a dosage of 2.5mg per day if \> 65 yrs. and 5 mg/per day if \<65 yrs. per day. Per physician discretion, participants are allowed a dose escalation of a maximum of 10mg.

Trial Locations (1)

07631

Englewood Health, Englewood

All Listed Sponsors
lead

Englewood Hospital and Medical Center

OTHER